Axcella Health Inc. AXLA NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

42/100

2/6 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Axcella Health Inc. (AXLA), dont 33 achats et 12 ventes. Le total des achats d'initiés s'élève à $40.59M et le total des ventes d'initiés à $456.1K.

Les initiés notables ayant une activité récente comprennent Koziel Margaret, Hinshaw William, Fehlner Paul. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — AXLA

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2023-03-01	Koziel Margaret	Chief Medical Officer	Vente Informative	679	$0.58	$393.82	24,883
2023-02-17	Hinshaw William	President & CEO	Attribution de RSU	275,000	$0.68	$185.87K	275,000
2023-02-17	Fehlner Paul	SVP & Chief Legal Officer	Attribution de RSU	70,000	$0.68	$47.31K	70,000
2023-02-17	Koziel Margaret	Chief Medical Officer	Attribution de RSU	70,000	$0.68	$47.31K	70,000
2023-02-10	Fehlner Paul	SVP & Chief Legal Officer	Achat Informatif	5,221	$0.66	$3.45K	58,081
2022-11-16	Rosiello Robert L.	Director	Attribution de RSU	40,000	-	-	40,000
2022-11-16	Nissen Torben Straight	Director	Attribution de RSU	40,000	-	-	40,000
2022-10-19	Hinshaw William	President & CEO	Vente Informative	16,000	$1.56	$25.03K	82,012
2022-10-17	Hinshaw William	President & CEO	Attribution de RSU	50,000	-	-	98,012
2022-10-13	Nestle Sa	Director	Achat Informatif	3,658,536	$1.64	$6M	11,105,438
2022-10-13	Afeyan Noubar	Director	Achat Informatif	3,048,780	$1.64	$5M	3,048,780
2022-10-13	Flagship Pioneering Inc.	Director	Inconnu	-	-	-	3,048,780
2022-10-13	Flagship Ventures Fund Iv General Partner Llc	10 Percent Owner	Achat Informatif	3,048,780	$1.64	$5M	3,048,780
2022-10-13	Societe Des Produits Nestle S.a.	10 Percent Owner	Achat Informatif	3,658,536	$1.64	$6M	11,105,438
2022-10-10	Rosiello Robert L.	Director	Inconnu	-	-	-	-
2022-10-10	Nissen Torben Straight	Director	Inconnu	-	-	-	-
2022-06-01	Koziel Margaret	Chief Medical Officer	Vente Informative	590	$2.01	$1.19K	26,109
2022-05-19	Rosenblatt Michael	Director	Cession	5,428	$13.83	$75.07K	-
2022-05-19	Rosenblatt Michael	Director	Attribution de RSU	40,000	$1.70	$68K	40,000
2022-05-19	Baird William D Iii	Director	Attribution de RSU	20,000	$1.70	$34K	20,000
2022-05-19	Sohn Catherine A.	Director	Attribution de RSU	20,000	$1.70	$34K	20,000
2022-05-19	Pisano Gary P.	Director	Attribution de RSU	20,000	-	-	20,000
2022-05-19	Rondinone Cristina	Director	Attribution de RSU	20,000	$1.70	$34K	20,000
2022-05-19	Hendrix Martin	Director	Inconnu	-	-	-	-
2022-05-19	Hendrix Martin	Director	Attribution de RSU	40,000	-	-	40,000
2022-05-19	Sekhri Paul J	Director	Inconnu	-	-	-	-
2022-05-19	Sekhri Paul J	Director	Attribution de RSU	40,000	$1.70	$68K	40,000
2022-05-19	Epstein David R	Director	Attribution de RSU	47,059	-	-	209,756
2022-03-17	Epstein David R	Director	Exercice d'Options (Vente)	1,535	-	-	-
2022-03-16	Nestle Sa	Director	Achat Informatif	3,141,361	$1.91	$6M	7,446,902
2022-03-16	Societe Des Produits Nestle S.a.	10 Percent Owner	Achat Informatif	3,141,361	$1.91	$6M	7,446,902
2022-03-16	Afeyan Noubar	Director	Achat Informatif	1,579,843	$1.91	$3.02M	4,465,866
2022-03-16	Crane Robert	Chief Financial Officer	Achat Informatif	39,267	$1.91	$75K	39,267
2022-03-16	Epstein David R	Director	Achat Informatif	26,178	$1.91	$50K	161,162
2022-03-16	Flagship Ventures Fund Iv General Partner Llc	10 Percent Owner	Achat Informatif	947,905	$1.91	$1.81M	2,004,657
2022-03-16	Hinshaw William	President & CEO	Achat Informatif	13,089	$1.91	$25K	48,012
2022-03-16	Fehlner Paul	SVP & Chief Legal Officer	Achat Informatif	10,471	$1.91	$20K	20,802
2022-03-01	Koziel Margaret	Chief Medical Officer	Vente Informative	553	$1.86	$1.03K	26,699
2022-02-18	Epstein David R	Director	Exercice d'Options (Vente)	1,534	-	-	1,535
2022-02-08	Hinshaw William	President & CEO	Attribution de RSU	100,000	$5.00	$500K	100,000
2022-02-08	Fehlner Paul	SVP & Chief Legal Officer	Attribution de RSU	70,000	$1.63	$114.1K	70,000
2022-02-08	Schecter Alison D.	President - Research & Dev.	Attribution de RSU	56,000	$1.63	$91.28K	56,000
2022-02-08	Dean Virginia R	SVP, Chief People Officer	Attribution de RSU	71,400	$1.63	$116.38K	71,400
2022-02-08	Koziel Margaret	Chief Medical Officer	Attribution de RSU	33,397	$1.63	$54.44K	33,397
2022-02-08	Crane Robert	Chief Financial Officer	Cession	200,000	$1.63	$326K	-
2022-01-31	Hinshaw William	President and CEO	Vente Informative	16,590	$1.65	$27.39K	33,410
2022-01-28	Hinshaw William	President and CEO	Exercice d'Options (Vente)	50,000	-	-	-
2022-01-18	Epstein David R	Director	Exercice d'Options (Vente)	1,535	-	-	3,069
2021-12-17	Epstein David R	Director	Exercice d'Options (Vente)	1,535	-	-	4,604
2021-12-10	Koziel Margaret	Chief Medical Officer	Attribution de RSU	75,000	$2.60	$195K	75,000

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration